BARCLAYS PLC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 187 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$6,857,000
+5614.2%
390,496
+3055.0%
0.00%
Q2 2021$120,000
+252.9%
12,377
+291.3%
0.00%
Q1 2021$34,000
+1033.3%
3,163
+1505.6%
0.00%
Q4 2020$3,000
-99.9%
197
-99.9%
0.00%
-100.0%
Q3 2020$4,964,000
+26.7%
349,300
-27.9%
0.00%0.0%
Q2 2020$3,917,000
+639.1%
484,239
+269.2%
0.00%
Q1 2020$530,000
+597.4%
131,170
+1149.2%
0.00%
Q4 2017$76,00010,5000.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
VR Adviser, LLC 4,040,000$59,428,0008.74%
Fairmount Funds Management LLC 1,478,181$21,744,0007.78%
COMMODORE CAPITAL LP 852,871$12,546,0006.82%
Ghost Tree Capital, LLC 1,950,000$28,685,0006.39%
Endurant Capital Management LP 655,741$9,646,0003.48%
FRAZIER MANAGEMENT LLC 3,053,107$44,879,0003.46%
ACUTA CAPITAL PARTNERS, LLC 803,000$11,812,0003.21%
NEA Management Company, LLC 5,736,363$84,382,0002.23%
Tri Locum Partners LP 296,838$4,366,0001.59%
Avidity Partners Management LP 3,185,200$46,854,0001.52%
View complete list of TRILLIUM THERAPEUTICS INC shareholders